Rodgers, J., Frahm, N., Fneish, F., Ellenberger, D., Haas, J., Loebermann, M., . . . Middleton, R. (2022). SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study. The Lancet Regional Health - Europe, 22, p. 100502. doi:10.1016/j.lanepe.2022.100502
Chicago Style CitationRodgers, Jeff, et al. "SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis in Germany and the United Kingdom: Gender-specific Results From a Longitudinal Observational Study." The Lancet Regional Health - Europe 22 (2022): 100502.
MLA CitationRodgers, Jeff, et al. "SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis in Germany and the United Kingdom: Gender-specific Results From a Longitudinal Observational Study." The Lancet Regional Health - Europe 22 (2022): 100502.